The effect of levetiracetam treatment on survival in patients with glioblastoma: a systematic review and meta-analysis.

Jia-Shu ChenRoss ClarkeAlexander F HaddadElaina J WangMichel LacroixIndra Neil SarkarRamin ZandElizabeth S ChenSteven A Toms

Published in: Journal of neuro-oncology (2022)

Levetiracetam treatment may not be effective for all GBM patients. Instead, LEV may be better suited for treating specific molecular profiles of GBM. Further studies are necessary to identify optimal GBM candidates for LEV.

Keyphrases

end stage renal disease
chronic kidney disease
ejection fraction
newly diagnosed
prognostic factors
combination therapy
patient reported outcomes